The metalloprotease disintegrin ADAM8 - Processing by autocatalysis is required for proteolytic activity and cell adhesion

Schlomann U, Wildeboer D, Webster A, Antropova O, Zeuschner D, Knight CG, Docherty AJP, Lambert M, Skelton L, Jockusch H, Bartsch JW (2002)
Journal of Biological Chemistry 277(50): 48210-48219.

Download
No fulltext has been uploaded. References only!
Journal Article | Original Article | Published | English

No fulltext has been uploaded

Author
; ; ; ; ; ; ; ; ; ;
Abstract / Notes
ADAMs (a disintegrin and metalloprotease domains) are metalloprotease and disintegrin domain-containing transmembrane glycoproteins with proteolytic, cell adhesion, cell fusion, and cell signaling properties. ADAM8 was originally cloned from monocytic cells, and its distinct expression pattern indicates possible roles in both immunology and neuropathology. Here we describe our analysis of its biochemical properties. In transfected COS-7 cells, ADAM8 is localized to the plasma membrane and processed into two forms derived either by prodomain removal or as remnant protein comprising the extracellular region with the disintegrin domain at the N terminus. Proteolytic removal of the ADAM8 propeptide was completely blocked in mutant ADAM8 with a Glu(330) to Gln exchange (EQ-A8) in the Zn2+ binding motif (HE(330)LGHNLGMSHD), arguing for autocatalytic prodomain removal. In co-transfection experiments, the ectodomain but not the entire MP domain of ADAM8 was able to remove the prodomain from EQ-ADAM8. With cells expressing ADAM8, cell adhesion to a substrate-bound recombinant ADAM8 disintegrin/Cys-rich domain was observed in the absence of serum, blocked by an antibody directed against the ADAM8 disintegrin domain. Soluble ADAM8 protease, consisting of either the metalloprotease domain or the complete ectodomain, cleaved myelin basic protein and a fluorogenic peptide substrate, and was inhibited by batimastat (BB-94, IC50 similar to50 nM) but not by recombinant tissue inhibitor of matrix metalloproteinases 1, 2, 3, and 4. Our findings demonstrate that ADAM8 processing by autocatalysis leads to a potential sheddase and to a form of ADAM8 with a function in cell adhesion.
Publishing Year
ISSN
eISSN
PUB-ID

Cite this

Schlomann U, Wildeboer D, Webster A, et al. The metalloprotease disintegrin ADAM8 - Processing by autocatalysis is required for proteolytic activity and cell adhesion. Journal of Biological Chemistry. 2002;277(50):48210-48219.
Schlomann, U., Wildeboer, D., Webster, A., Antropova, O., Zeuschner, D., Knight, C. G., Docherty, A. J. P., et al. (2002). The metalloprotease disintegrin ADAM8 - Processing by autocatalysis is required for proteolytic activity and cell adhesion. Journal of Biological Chemistry, 277(50), 48210-48219. doi:10.1074/jbc.M203355200
Schlomann, U., Wildeboer, D., Webster, A., Antropova, O., Zeuschner, D., Knight, C. G., Docherty, A. J. P., Lambert, M., Skelton, L., Jockusch, H., et al. (2002). The metalloprotease disintegrin ADAM8 - Processing by autocatalysis is required for proteolytic activity and cell adhesion. Journal of Biological Chemistry 277, 48210-48219.
Schlomann, U., et al., 2002. The metalloprotease disintegrin ADAM8 - Processing by autocatalysis is required for proteolytic activity and cell adhesion. Journal of Biological Chemistry, 277(50), p 48210-48219.
U. Schlomann, et al., “The metalloprotease disintegrin ADAM8 - Processing by autocatalysis is required for proteolytic activity and cell adhesion”, Journal of Biological Chemistry, vol. 277, 2002, pp. 48210-48219.
Schlomann, U., Wildeboer, D., Webster, A., Antropova, O., Zeuschner, D., Knight, C.G., Docherty, A.J.P., Lambert, M., Skelton, L., Jockusch, H., Bartsch, J.W.: The metalloprotease disintegrin ADAM8 - Processing by autocatalysis is required for proteolytic activity and cell adhesion. Journal of Biological Chemistry. 277, 48210-48219 (2002).
Schlomann, U, Wildeboer, D, Webster, A, Antropova, O, Zeuschner, D, Knight, CG, Docherty, AJP, Lambert, M, Skelton, L, Jockusch, Harald, and Bartsch, JW. “The metalloprotease disintegrin ADAM8 - Processing by autocatalysis is required for proteolytic activity and cell adhesion”. Journal of Biological Chemistry 277.50 (2002): 48210-48219.
This data publication is cited in the following publications:
This publication cites the following data publications:

70 Citations in Europe PMC

Data provided by Europe PubMed Central.

Elevated soluble ADAM8 in bronchoalveolar lavage fluid in patients with eosinophilic pneumonia.
Matsuno O, Miyazaki E, Nureki S, Ueno T, Ando M, Ito K, Kumamoto T, Higuchi Y., Int Arch Allergy Immunol 142(4), 2007
PMID: 17124430
Identification of candidate substrates for ectodomain shedding by the metalloprotease-disintegrin ADAM8.
Naus S, Reipschläger S, Wildeboer D, Lichtenthaler SF, Mitterreiter S, Guan Z, Moss ML, Bartsch JW., Biol Chem 387(3), 2006
PMID: 16542157
(Make) stick and cut loose--disintegrin metalloproteases in development and disease.
Tousseyn T, Jorissen E, Reiss K, Hartmann D., Birth Defects Res C Embryo Today 78(1), 2006
PMID: 16622847
Control of ErbB signaling through metalloprotease mediated ectodomain shedding of EGF-like factors.
Sanderson MP, Dempsey PJ, Dunbar AJ., Growth Factors 24(2), 2006
PMID: 16801132
Implication of ADAM-8, -9, -10, -12, -15, -17, and ADAMTS-1 in implantational remodeling of a mouse uterus.
Kim J, Kang SG, Kim JI, Park JH, Kim SK, Cho DJ, Kim H., Yonsei Med J 47(4), 2006
PMID: 16941747
ADAM8 expression in prostate cancer is associated with parameters of unfavorable prognosis.
Fritzsche FR, Jung M, Xu C, Rabien A, Schicktanz H, Stephan C, Dietel M, Jung K, Kristiansen G., Virchows Arch 449(6), 2006
PMID: 17106710
Metalloprotease-disintegrin ADAM8: expression analysis and targeted deletion in mice.
Kelly K, Hutchinson G, Nebenius-Oosthuizen D, Smith AJ, Bartsch JW, Horiuchi K, Rittger A, Manova K, Docherty AJ, Blobel CP., Dev Dyn 232(1), 2005
PMID: 15580619
ADAMs: key components in EGFR signalling and development.
Blobel CP., Nat Rev Mol Cell Biol 6(1), 2005
PMID: 15688065
Two separate metalloproteinase activities are responsible for the shedding and processing of the NG2 proteoglycan in vitro.
Asher RA, Morgenstern DA, Properzi F, Nishiyama A, Levine JM, Fawcett JW., Mol Cell Neurosci 29(1), 2005
PMID: 15866049
The facial motor nucleus transcriptional program in response to peripheral nerve injury identifies Hn1 as a regeneration-associated gene.
Zujovic V, Luo D, Baker HV, Lopez MC, Miller KR, Streit WJ, Harrison JK., J Neurosci Res 82(5), 2005
PMID: 16267826
Mouse ADAM33: two splice variants differ in protein maturation and localization.
Umland SP, Wan Y, Shah H, Garlisi CG, Devito KE, Braunschweiger K, Gheyas F, Del Mastro R., Am J Respir Cell Mol Biol 30(4), 2004
PMID: 12972401
ADAM proteins in the brain.
Novak U., J Clin Neurosci 11(3), 2004
PMID: 14975408
Novel metalloprotease-disintegrin, meltrin epsilon (ADAM35), expressed in epithelial tissues during chick embryogenesis.
Watabe-Uchida M, Masuda A, Shimada N, Endo M, Shimamura K, Yasuda K, Sehara-Fujisawa A., Dev Dyn 230(3), 2004
PMID: 15188440
ADAM23 is a cell-surface glycoprotein expressed by central nervous system neurons.
Goldsmith AP, Gossage SJ, ffrench-Constant C., J Neurosci Res 78(5), 2004
PMID: 15505805
Identification of genes that are induced after cadmium exposure by suppression subtractive hybridization.
Shin HJ, Park KK, Lee BH, Moon CK, Lee MO., Toxicology 191(2-3), 2003
PMID: 12965115

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 12372841
PubMed | Europe PMC

Search this title in

Google Scholar